Flavonoid of Drynaria fortunei protects against acute renal failure

Phytotherapy Research

Volumn 19, Issue 5, 2005, Pages 422-427

  Long, Mian ^a   Qiu, Dan ^a   Li, Fangrong ^b   Johnson, Francis ^a   Luft, Benjamin ^a  

^a STONY BROOK UNIVERSITY   (United States)

^b HUNAN UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Drynaria fortunei; Flavonoid; Gu Sui Bu; Kidney; Renal failure; Tubular regeneration

Indexed keywords

CREATINE; DRYNARIA FORTUNEI EXTRACT; FLAVONOID; GENTAMICIN; HERBACEOUS AGENT; MERCURIC CHLORIDE; PLANT EXTRACT; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ACUTE KIDNEY FAILURE; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOLOGICAL ACTIVITY; CELL REGENERATION; CONTROLLED STUDY; GUINEA PIG; KIDNEY CELL; KIDNEY FUNCTION; KIDNEY TUBULE CELL; MOUSE; NEPHRECTOMY; NEPHROTOXICITY; NONHUMAN; SURVIVAL TIME; UREA NITROGEN BLOOD LEVEL;

ANIMALS; CREATININE; DISEASE MODELS, ANIMAL; GENTAMICINS; GUINEA PIGS; KIDNEY FAILURE, ACUTE; KIDNEY TUBULES; MERCURIC CHLORIDE; MICE; PHYTOTHERAPY; PLANT EXTRACTS; POLYPODIACEAE; PROTECTIVE AGENTS; UREA;

ANIMALIA; CAVIA; DRYNARIA;

EID: 24644452547     PISSN: 0951418X     EISSN: None     Source Type: Journal    
DOI: 10.1002/ptr.1606     Document Type: Article

References (15)

1. Ash SH, Thornhill JA (eds). 1985. Handbook of Animal Models of Renal Failure. CRC Press: Boca Raton, FL.
2. Barsotti G, Cupisti A, Dani L, et al. 1986. Protection of renal function in subtotally nephrectomized rats by dietary therapy. Contr Nephrol 53: 21-30.
3. Bensky D, Gamble A. 1996. Chinese Herbal Medicine: Materia Medica. Eastland Press: Seattle.
4. Cai Q, Li X, Wang H. 2001. Astragali and Angelica protect the kidney against ischemia and reperfusion injury and accelerate recovery. Chin Med J 114: 119-123.
5. Clayton PE, Cowell CT. 2000. Safety issues in children and adolescents during growth hormone therapy - a review. Growth Horm IGF Res 10: 306-317.
6. Kawaida K, Matsumoto K, Shimazu H, Nakamura T. 1994. Hepatocyte growth factor prevents acute renal failure and accelerates renal regeneration in mice Proc Nat Acad Sci USA 91: 4357-4361.
7. Laping NJ. 1999. Hepatocyte growth factor in renal disease: cause or cure? Cell Mol Life Sci 56: 371-377.
8. Li SX, Long M, Zhang ZG. 2002. Review of study on Drynaria fortunei. J Tradit Chin Med News (Zhong Yi Yao Xin Xi. Chinese), 9(11): 75-78.
9. Long L, Smouha E, Qiu D, Li F, Johnson F, Luft B. 2004. Flavonoid of Drynaria fortunei protects gentamicin ototoxicity. submitted to Phytother Res 18: 609-614.
10. Ma Z, Wang R, Qiu M. 1999. Study of morphologic effects of 4 Chinese herbs by bone histomorphometry in ovariectomized rats. [Chinese] Chung-Hua Fu Chan Ko Tsa Chih. Chin J Obstet Gynecol 34: 82-85.
11. Malluche HH, Monier-Faugere MC, Koszewski NJ. 2002. Use and indication of vitamin D and vitamin D analogues in patients with renal bone disease. Nephrol Dial Transplant 17(Suppl 10): 6-9.
12. Matsumoto K, Nakamura T. 2002. Renotropic role and therapeutic potential of HGF in the kidney. Nephrol Dial Transplant 17(Suppl 9): 59-61.
13. Ritz E, Eisenhardt A. 2000. Early epoetin treatment in patients with renal insufficiency. Nephrol Dial Transplant 15(Suppl 3): 40-44.
14. Santos S, Bosch RJ, Ortega A, et al. 2001. Up-regulation of parathyroid hormone-related protein in folic acid-induced acute renal failure. Kidney Int 60: 982-995.
15. Venkata C, Ram S, Fierro G. 1998. The benefits of angiotensin II receptor blockers in patients with renal insufficiency or failure. (Review). Am J Ther 5: 101-105.